 | Dynavax Technologies Corporatio | |||
| NMS : DVAX || Location: United States | ||||
$11.42-0.34 (-2.89%) |
1.46 M | 11.35 - 11.75 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 17.966 M |
| March 15, 2024 | 17.348 M |
| Feb. 29, 2024 | 16.368 M |
| Feb. 15, 2024 | 14.998 M |
| Jan. 31, 2024 | 14.330 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.02 | 0.10 | 753.59% |
| 06/30/2023 | -0.09 | 0.03 | 132.05% |
| 03/31/2023 | -0.14 | -0.19 | -40.53% |
| 12/31/2022 | 0.44 | 0.45 | 3.19% |
| 09/30/2022 | 0.33 | 0.43 | 30.30% |
DVAX Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 130.863M | Shares Float | 123.059M |
| Short Float | 17.966M | Market Cap | 1494.46M |
| Institution ownership | 97.99% | Insider ownership | 0.311% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.05 | Forward EPS | 0.50 |